Araris Biotech and Chugai Pharmaceutical Partner to Advance Next-Generation Cancer Therapies
By Daniella Parra Araris Biotech AG, a Swiss oncology biotech firm, has partnered with Chugai Pharmaceutical to develop advanced antibody-drug conjugates (ADCs) using Araris’ AraLinQ...